Alternative splicing of FPGS has been shown to affect drug metabolism and resistance in acute lymphoblastic leukemia (ALL) by modulating folate homeostasis [38], and since the folate has been shown to improve MASLD [39], similar splicing alterations of FPGS may also influence fatty liver development. Here, FPGS is linked to acute lymphoblastic leukemia.